The North American Thrombosis Forum (NATF)
Avatar

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

By The North American Thrombosis Forum (NATF) FEATURING Christian Cruff
By The North American Thrombosis Forum (NATF) FEATURING Christian Cruff
593 views
October 15, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
15:06
Houston Methodist DeBakey Heart and Vascular Center

EKG Interpretations: A Non-Cardiologist Must Know

Feat. P. Schurmann
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
13:54
Stanford Medicine

How I Manage Patients with Frequent PVCs

Feat. R. John
18:36
The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi
22:57
The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

Feat. C. Ruff, J. Walker
02:38
Boston Scientific

LUX-Dx II+ ICM Atrial Tachycardia Algorithm

57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
06:32
Mayo Clinic Proceedings

Premature Atrial Contraction Frequency and Cognitive Function

Feat. L. Yee Chen
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile